Skip to main content
Eurostyle Collection Lisboa Table Lamp by Gilt <img src="https://chart.googleapis.com/chart?cht=qr&chs=200x200&chl=https%3A%2F%2Fapi.shopstyle.com%2Faction%2FapiVisitRetailer%3Fid%3D687775003%26pid%3Duid1456-40284116-11%26utm_content%3Dqr-code">
Post a Comment

ALL ABOUT MS Symptoms of MS (Part 5)

Sexual function disorders

Sexual function disorders in MS are one of the most unusual manifestations of this disease most talked about by doctors. Precise frequency data does not take into account the fact that the problem of sexual disorders in MS is not given much attention during routine neurological examination, but it is estimated that about 62-83% of MS sufferers suffer from some type of sexual function disorder.


Because similar nervous webs control the function of the bladder and genital organs, sexual disorders are often associated with urinary disorders. They occur more often in patients with weakness and numbness of the leg.
Factors that affect the occurrence and severity of sexual function disorders in patients with MS are the activity of the disease which leads to variations in the manifestation of these symptoms, decreased touch sensitivity, psychological factors and depression, the presence of pain and an unpleasant tingling, disorders of urinary and defecation functions, fatigue (spasticity), fatigue, the use of certain drugs (antidepressants), and misunderstanding and misunderstanding of the nature of these symptoms by the partner.

The most common misconceptions about sexual disorders in patients with MS are:
1. I have MS and sexual disorders are the least important in this disease.
2. Patients with impaired walking do not have sexual needs.
3. My doctor is not interested in listening to my sexual problems.
4. It's not right to talk to a doctor about sexual problems.
5. Sexual relationship must end with an orgasm.
6. The physical relationship between partners must include sexual actions.
7. People must instinctively be sexually competent.
8. Patients should not masturbate or have sexual fantasies.

The most common disorders of sexual function in men with MS are impotence (erectile disorder) and ejaculation disorders.
It is estimated that about 70% of MS men have a potency problem, primarily with achieving and maintaining an erection as well as experiencing an orgasm. Impotence in the patient of this disease is thought to be caused by changes that damage the lower spinal bone. The average time of occurrence of this disorder is about 9 years since the onset of the disease and is mainly developed after the occurrence of problems with urinary incontinence.

Vardenafil (Levitra) is recommended as the most effective therapy for the treatment of erectile dysfunction (impotence). A positive therapeutic effect on erectile dysfunction and ejaculation, as well as the rise in sexual desire, are also shown by Yohimhin tablets (10-20 mg) taken about two hours before sexual intercourse. If these two preparations do not prove to be effective, it is possible to apply local procedures: Injection injection into the body of the penis substances called papaverine and prostaglandins. Usually an effective dose in MS is about 5-10 mg of papaverine. If, however, there are difficulties in achieving an orgasm, it is recommended to stimulate the vibrator on the front of the full body.

The most common sexual function disorders in women with MS are the lack of vaginal wetting, loss of touch sensation, inability to reach orgasm and unpleasant sensation in the vaginal region during the relationship. The occurrence of these symptoms in women is almost always associated with disorders of the bladder function.

This type of disorder can be partially treated. The lack of vaginal wetting can be overcome by local
use of various wetting gels, while other disorders, unfortunately, can be difficult to influence with drugs. In case of unpleasant sensations during sexual intercourse, it is recommended to take medicines that are otherwise given in the treatment of unhealthy sensory experiences in other parts of the body, such as antiepileptics (gabapentin, carbamazepine). Touch sensitivity can not be corrected by any drug, but the use of a vibration stimulator is recommended. In addition, studies are under way in the world to deal with the possible positive therapeutic effect of sildenafil in women with sex-related disorders due to MS.
Labels:

Comments

Post a Comment

Popular posts from this blog

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS  Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...
Post a Comment
Read more

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...
Post a Comment
Read more

ALL ABOUT MS Symptoms of MS (Part 4)

Urinary disorders About one-third of patients have sphincter disorders: an overwhelming need for urinary incontinence, which can sometimes be accompanied by frequent urination (so-called polacizuria), difficulty in urinating, retention (complete inability to urinate) and incontinence (loss of control over the process urinating, so that the urinary bladder empties reluctantly and unexpectedly). Urinary disorders can be accompanied by constipation and incontinence of the stool and impotence. Urinary disorders are very disturbing disorders, which significantly affect the quality of life, personal, professional and social functioning of the patients. Urinary disorders in MS are very common and occur in approximately 96% of patients with MS after 10 years of illness. Urinary disorders can occur at any time during the course of the disease, even at its inception (in about 2% of patients). Some researchers believe that patients in whom the disease begins with problems in the...
Post a Comment
Read more